Deutsche Bank
CADL icon

Deutsche Bank’s Candel Therapeutics CADL Stock Holding History

Deutsche Bank’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$648K Buy
62,941
+29,641
+89% +$224K ﹤0.01% 2631
2026
Q1 		$163K Buy
33,300
+4,925
+17% +$26.8K ﹤0.01% 3086
2025
Q4 		$160K Buy
28,375
+1,716
+6% +$9.23K ﹤0.01% 3116
2025
Q3 		$136K Buy
26,659
+5,034
+23% +$29.1K ﹤0.01% 3231
2025
Q2 		$109K Sell
21,625
-4,586
-17% -$23.6K ﹤0.01% 3216
2025
Q1 		$148K Sell
26,211
-5,311
-17% -$43.4K ﹤0.01% 3077
2024
Q4 		$274K Buy
31,522
+30,989
+5,814% +$183K ﹤0.01% 2958
2024
Q3 		$3.69K Buy
533
+465
+684% +$2.89K ﹤0.01% 3549
2024
Q2 		$422 Buy
+68
New +$510 ﹤0.01% 3538

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank's CADL Position: Q2 2026 in Review

Deutsche Bank increased its Candel Therapeutics (CADL) stake by 89% in Q2 2026, buying an estimated $224K and bringing the position to 62,941 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Deutsche Bank first reported a position in CADL in Q2 2024 and has held it in 9 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Deutsche Bank held 62,941 shares of Candel Therapeutics worth $648K as of Q2 2026.
  • Deutsche Bank bought 29,641 Candel Therapeutics shares in Q2 2026, an estimated $224K.
  • Candel Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2631 holding.
  • Deutsche Bank first reported a position in Candel Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.